🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Nick Xue from Dr. Kovacs lab at Schulich WesternU presenting his work on radio labelling of monoclonal antibodies at the 6th IO symposium

Proud PI moment: Megan Hong received the top oral presentation award and Tiffany Cheung received the top poster presentation award at the 6th Immuno-Oncology Symposium at Schulich WesternU and London Health Sciences Centre Research Institute

Maleki lab, Spring 2025 version. Schulich WesternU London Health Sciences Centre Research Institute

We had a great day attending the 6th Immuno-Oncology Symposium CTCR. Congratulations to CMIG and Ronald lab students Sean McRae and Jasmine Lau who took home poster awards and Rafael Sanchez and Alexa Smith who gave fantastic poster and oral presentations 👏 #CTCRIO2025

STAT5 and STAT3 balance shapes DC function and tumor immunity nature nature.com/articles/s4158…

Join us on TODAY, from 12:00 - 1:00 p.m., for a Zoom Meeting, as Dr. Bekim Sadikovic, discusses “DNA methylation episignatures as biomarkers in rare disorders and beyond.” schulich.uwo.ca/pathol/events/…

Congratulations to all future doctors who got a call today from Schulich WesternU, including my 4th year PathologyLabMedicine student Anorin Ali.

Saw a big❤️& a note apologizing for blocking the kitchen window, saying a 6-year-old with leukemia is being treated in the building across, who looks directly at our window & sees this heart as a sign of love for her as she goes through cancer treatment. Love my London Health Sciences Centre Research Institute collegues

I’ve been in the exercise oncology field for 20 years and for all of that time, the main criticism has been “show me a well controlled RCT.” Well, here it is. Exercise following adjuvant chemotherapy for colon cancer reduced recurrence and improves OVERALL SURVIVAL! #ASCO25

Read our review on gut #microbiome as a target for #cancer #immunotherapy at Nature Reviews Drug Discovery

1/2: Fc-active CTLA-4 antagonists produce dramatic results in cold tumors eg MSS CRC. Efficacy is often associated with high irAE incidence affecting drug exposure. Vilastobart (XTX-101) is a differentiated Fc-active anti-CTLA-4 which is TME selective. Dr. Marwan G. Fakih Pashtoon Kasi MD, MS

Highlighting the importance of distinguishing prognostic versus predictive scores/biomarkers ncbi.nlm.nih.gov/books/NBK40228…

A successful Department of Oncology Annual R&E Day led by me and my co-chair, Dan Breadner, with an amazing keynote talk from Diwakar Davar, M.D. and great oral and poster presentations by our trainees and a very engaging Translational Research Panel. Schulich WesternU London Health Sciences Centre Research Institute

How gut inflammation can induce brain inflammation nature.com/articles/s4158… nature

NEW content online! Endoplasmic reticulum stress responses in anticancer immunity bit.ly/4ei3dFN

When you are a #microbiome researcher who likes plants and papers, that's what your team gets you for your birthday. Schulich WesternU London Health Sciences Centre Research Institute

Types of Coffee ☕

Published nature : Air pollution may drive TP53 and other mutations in lung cancer among never-smokers. EGFR was common in East Asia, KRAS in the West; secondhand smoke showed minimal genomic impact, and herbal toxin–linked signatures were seen in Taiwan.

RIP Dr. Eshhar.

NIH announces end to funding for animal-only studies drugdiscoverytrends.com/nih-announces-…